The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and outcomes of immunotherapy re-challenge in lung cancer.
 
Xinyu Nan
No Relationships to Disclose
 
Paulette Gabbai-Saldate
No Relationships to Disclose
 
Sandip Pravin Patel
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Compugen; Illumina; Lilly; Nektar; Novartis
Speakers' Bureau - Boehringer Ingelheim; Merck
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Blueprint Medicines; Boehringer Ingelheim; G1 Therapeutics; Genentech/Roche; Loxo; Novartis; Takeda
Research Funding - BeyondSpring Pharmaceuticals
 
William M. Mitchell
No Relationships to Disclose
 
Kathryn A. Gold
Consulting or Advisory Role - AstraZeneca; Rakuten Medical; Regeneron; Takeda
Speakers' Bureau - Takeda
Research Funding - Abbvie; ARIAD; AstraZeneca; Bristol-Myers Squibb; Pharmacyclics; Roche/Genentech